Sarvajna Dwivedi, Ph.D. is the Co-Founder, Investor, and Board Member at AngioSafe, Inc., where Sarvajna is focused on solving challenges in complex vascular interventions. Sarvajna has a background in pharmaceutical sciences and has held various leadership roles in companies such as AstraZeneca, Pearl Therapeutics, and Nektar Therapeutics. Sarvajna is known for their expertise in developing early medicines, devices, and new modalities in the pharmaceutical industry.
This person is not in any teams
AngioSafe, Inc.
AngioSafe is a pre-commercial stage company developing a pipeline of devices to address the challenges of complexity, safety and efficacy of cardiovascular interventions in peripheral and coronary artery disease.